Advances in Interventional Neuroradiology 2007
2008; Lippincott Williams & Wilkins; Volume: 39; Issue: 2 Linguagem: Inglês
10.1161/strokeaha.107.510628
ISSN1524-4628
AutoresDavid M. Pelz, Elad I. Levy, L. Nelson Hopkins,
Tópico(s)Acute Ischemic Stroke Management
ResumoHomeStrokeVol. 39, No. 2Advances in Interventional Neuroradiology 2007 Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBAdvances in Interventional Neuroradiology 2007 David M. Pelz, Elad I. Levy and L. Nelson Hopkins David M. PelzDavid M. Pelz From the University Hospital (D.M.P.), London Health Sciences Centre, Departments of Diagnostic Radiology and Nuclear Medicine, and Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada; Department of Neurosurgery (E.I.L., L.N.H.), Millard Fillmore Gates Hospital, Kaleida Health; Departments of Neurosurgery and Radiology and Toshiba Stroke Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University New York, Buffalo, New York, USA. , Elad I. LevyElad I. Levy From the University Hospital (D.M.P.), London Health Sciences Centre, Departments of Diagnostic Radiology and Nuclear Medicine, and Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada; Department of Neurosurgery (E.I.L., L.N.H.), Millard Fillmore Gates Hospital, Kaleida Health; Departments of Neurosurgery and Radiology and Toshiba Stroke Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University New York, Buffalo, New York, USA. and L. Nelson HopkinsL. Nelson Hopkins From the University Hospital (D.M.P.), London Health Sciences Centre, Departments of Diagnostic Radiology and Nuclear Medicine, and Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada; Department of Neurosurgery (E.I.L., L.N.H.), Millard Fillmore Gates Hospital, Kaleida Health; Departments of Neurosurgery and Radiology and Toshiba Stroke Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University New York, Buffalo, New York, USA. Originally published10 Jan 2008https://doi.org/10.1161/STROKEAHA.107.510628Stroke. 2008;39:268–272Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 10, 2008: Previous Version 1 The year 2007 brought further understanding of the risk for subgroups of patients undergoing carotid artery stenting (CAS). For symptomatic patients, both increasing age and treatment within 2 weeks of neurological symptoms were associated with increased risk of perioperative stroke or death.1 Unfavorable anatomic factors for CAS among octogenarians included aortic arch elongation, calcification, great vessel origin stenosis, tortuosity, and severity of lesion stenosis,2 and the combined perioperative stroke/ myocardial infarction/death rate was 10.8% for this group.2 Diabetic patients ≥75 years undergoing CAS have 4.3× greater risk for any stroke/death and 12.0× greater risk for major stroke/death, whereas diabetics 36 hours occurred in 11%.9A protocol for comprehensive blood pressure management initiated in conjunction with CAS was shown to significantly reduce the incidence of intracerebral hemorrhage in all patients and both hyperperfusion syndrome and intracerebral hemorrhage in high-risk patients.10A number of industry supported registries continue to supply interesting data. Carotid artery stenting with emboli protection surveillance post-marketing study (CASES-PMS) demonstrated a 30-day stroke/myocardial infarction/death rate of 5.0% for a mixed group of symptomatic and asymptomatic patients.11 The Carotid ACCULINK/ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events (CAPTURE) postapproval registry reported a 30-day stroke/myocardial infarction/death rate of 6.3%, and both registries have shown no difference in outcomes based on level of operator experience.12 Complication rates in both were similar to Asymptomatic Carotid Atherosclerosis Study (ACAS) and North American Symptomatic Carotid Endarterectomy Trial (NASCET), and there was some relationship to CAS operator experience. Three-year follow-up data from registries using Boston Scientific devices confirmed higher risk of CAS in octogenarians, symptomatic patients, and those with medical comorbidities. In these high-risk cohorts, the incidence of perioperative stroke was up to 7.7%.13Primary stenting consists of carotid stent placement without embolic protection or intentional use of balloon angioplasty. Results among 87 consecutive patients with carotid stenosis treated with primary stent placement revealed 98% procedural success, 2% stroke/death, and 5% with periprocedural transient ischemic attacks.14In the United States, the Centers for Medicare and Medicaid Services (CMS) proposal to expand coverage of CAS essentially maintained the 2005 policy.15 Coverage continues for high-surgical-risk patients with symptomatic stenosis >70%. High-risk symptomatic patients with 50% to 70% stenosis are covered within FDA-approved clinical trials. The Carotid Revascularization Endarterectomy versus Stent Trial (CREST) study of CEA versus CAS will likely reach its recruitment goal of 2500 patients in early 2008. The results of this randomized trial are eagerly awaited.Intracranial Angioplasty and StentingWingspan stents (Boston Scientific) are now widely used for the treatment of symptomatic intracranial stenosis. In a group of 45 patients, the 30-day stroke/death rate was 4.5%.16 At 6 months, stenosis improved from 74% to 28%; the rate of all-cause stroke was 9.7% and that of all-cause mortality was 2.3%. Another prospective registry found a 29.7% rate of in-stent restenosis (>50%) plus an additional 4.8% occlusion rate at a mean of 5.9 months follow-up.17 The restenosis or occlusion was symptomatic in 28% of patients and required retreatment in 52%.A study comparing symptomatic severe (≥70%) and moderate (50% to 70%) intracranial stenosis in patients treated with balloon-expandable stents found no significant difference in stroke or hemorrhage rates either perioperatively or at the 1- and 2-year follow-up.18 In the multivariate analysis, stent failure was associated with adverse events in the severe stenosis group. In another report, balloon-mounted stent placement for symptomatic vertebrobasilar stenosis resulted in 26.1% perioperative morbidity and mortality.19 In-stent restenosis or occlusion occurred in 12.5% by 6 months, all of which were symptomatic.Acute Stroke TherapySeveral acute stroke therapy trials were reported in 2007. Interventional Management of Stroke (IMS) II found a 9.9% rate of symptomatic intracerebral hemorrhage after combination IV-intra-arterial (IA) tissue-type plasminogen activator therapy was administered within 3 hours of acute stroke onset,20 higher than the rate observed in the NINDS tissue-type plasminogen activator trial.21 A randomized trial is under way (IMS III) to determine whether an IV-IA approach to recanalization is superior to standard IV tissue-type plasminogen activator alone when initiated within 3 hours of stroke onset. Further results from the MERCI and Multi-MERCI investigators22,23 have shown that successful recanalization of acute distal ICA and proximal middle cerebral artery occlusions can be achieved in 53% to 63% of patients using the MERCI retriever (Concentric Medical) alone or in combination with IV/IA thrombolytics, yet symptomatic hemorrhages occurred in 6% of those patients who recanalized. Good clinical outcomes (modified Rankin Score ≤2) are more likely in those who recanalize than in those who don't (39% versus 3%), yet the 90-day mortality rate is still 30%. Another approach in those who fail MERCI retrieval has been to use angioplasty24 or self-expanding stents25,26 to compress friable clot and allow better penetration of thrombolytic agents. Recanalization rates of up to 89% with balloons and 79% with stents have been achieved in small numbers of patients, yet clinical outcomes manifested by modified Rankin Score ≤2 at 3 months remain at approximately 50% or less. Reports of aggressive revascularization of acute ICA and tandem ICA/middle cerebral artery occlusions using stents and intracranial thrombolysis have demonstrated the feasibility of this approach, again in small numbers of patients27,28,29 with recanalization rates of up to 100%, yet good modified Rankin Score scores at 3 and 11 months of only 30% to 40%. Attempts to identify prognostic factors for hemorrhagic complications and eventual clinical outcomes in patients undergoing these aggressive multimodal interventions showed that residual distal occlusions, tandem occlusions, larger initial pretreatment CT infarct size by Alberta Stroke Program Early CT Score (ASPECTS) score, hyperglycemia and use of both IA and IV thrombolytics were all associated with negative results.28,30 Novel mechanical revascularization strategies used deflated microballoon catheters31 and the Alligator retrieval device (Chestnut Medical Technologies)32 to open vessels that may be refractory to IA thrombolytics or the MERCI device.AneurysmsAdvances in the endovascular therapy of cerebral aneurysms include the refinement and improved evaluation of current technology, the introduction of several innovative stent devices, more detailed investigation of aneurysm healing mechanisms, and continuing debate on the best management for asymptomatic, unruptured aneurysms. Large, industry supported registries which have been used in the past to promote the use of modified coils have been criticized for their failure to demonstrate advantages over bare platinum. New, randomized trials are underway to determine whether these coils really result in decreased recurrence rates without increased complications.33,34 The widespread use of balloon-assisted coiling with low complication rates is allowing better endovascular management of complex aneurysms.35,36There are new stents being used to assist in the coiling of wide-necked aneurysms, such as the closed-cell design Enterprise (Cordis Neurovascular, Inc), the electrodetachable, fully retrievable Solo (eV3 Neurovascular) and the covered, balloon-expandable Willis (Microport).33,37,38 Development of significant focal stenosis remains a problem, seen in up to 5.8% of stent-assisted cases. A novel approach is to use a high-coverage, endoluminal mesh to divert flow and thus induce aneurysm thrombosis. The Pipeline Neuroendovascular Device (Chestnut Medical Technologies) is a tubular, bimetallic implant with approximately 30% coverage by area. In experimental, elastase-induced aneurysms in rabbits, it was found to be highly trackable, adequately radiopaque and resulted in 88% complete or near complete obliteration without the use of coils. There was minimal neointimal hyperplasia, and patency of small branch arteries covered by the device.39 Preliminary experience in humans has been encouraging.40New insights into the molecular and genetic factors underlying the healing of experimental swine aneurysms has led to refined evaluation of the effects of different polymers on this process.41,42 It is hoped that immunohistochemical and molecular biological data can be used to develop biologically active endovascular devices in the future. A novel method for depositing viable, migration capable fibroblasts on coils and successfully passing them through microcatheters may be a promising technique for endovascular intervention.43Continuing evaluation of data from the International Subarachnoid Aneurysm Trial (ISAT) has shown that late retreatment is almost 7 times more likely in the coiling group (17.4% of 1096 patients) than in the surgical cohort, although the incidence of delayed rebleeding was similar up to 8 years. Long-term imaging follow-up is still essential.44,45 There is mounting evidence that this follow-up can be done noninvasively using MR angiography,46,47 thus obviating the need for catheter angiography. Multidetector CT angiography may often be the only investigation needed to detect and plan the treatment of most cerebral aneurysms.48The debate over best management of asymptomatic, unruptured aneurysms continues, with champions49 and critics50,51,52 of the International Study of Unruptured Intracranial Aneurysms (ISUIA). Although there is some retrospective data favoring endovascular therapy,53 most investigators agree that a randomized, controlled trial including endovascular and surgical arms is necessary.AVMsNo new embolic agents for the endovascular therapy of brain AVMs have been used in humans, although an interesting modification to enhance the effects of Onyx (eV3 Neurovascular) with mannitol has been described.54 In this scenario, 25% mannitol was infused before intraarterial injection of Onyx to cause hyperosmotic vessel injury and promote thrombosis of brain, head and neck and dural AVMs in 22 patients. A new nonadhesive liquid embolic agent similar to Onyx has been tested in the swine rete with promising results. Eudragit-E 100 Polymer has a lower viscosity than Onyx, is injected slowly, has no catheter compatibility issues and generates an inflammatory response similar to the cyanoacrylates.55 The treatment decision algorithms for both ruptured and unruptured brain AVMs remain uncertain, and the recently launched A Randomized Trial of Unruptured Brain AVMs (ARUBA) will hopefully provide valid answers for those patients with incidentally discovered lesions.56 There are now 20 participating centers in North America.VasospasmData from ISAT has confirmed what many investigators have shown in smaller series: that there is no significant difference in the incidence of symptomatic vasospasm between surgical and endovascular groups.44 No new interventional strategies for dealing with symptomatic, posthemorrhagic cerebral vasospasm have been developed, although more compliant balloons for angioplasty are becoming available. An NIH funded, randomized trial of prophylactic balloon angioplasty versus standard medical therapy for vasospasm is currently underway.57Advances in TechnologyQuantitative frequency-domain near-infrared spectroscopy provides continuous, noninvasive information about brain oxygenation, including oxyhemoglobin and deoxyhemoglobin concentrations.58 This can provide valuable information during and following acute interventions for stroke, vasospasm and cerebrovascular atherosclerosis. The diagnostic accuracy of transcranial Doppler imaging and MR angiography was found to compare favorably to catheter angiography in patients with intracranial atherosclerotic stenosis.59 Transcranial Doppler studies may be of value for supplying diagnostic information in acute stroke patients, with good positive predictive value and negative predictive value relative to CT angiography.60 Color-coded duplex sonography has been used to evaluate vessels for recanalization after IV thrombolysis in acute stroke patients.61We thank Rodney M. Samuelson, MD, Babak S. Jahromi, MD, PhD, and Miguel Bussiere, MD, PhD, FRCPC, for reviewing the literature and assistance with the preparation of this manuscript, and Cathy Carlisle for final manuscript preparation.Sources of FundingDr Levy receives grant support from Boston Scientific Corporation and Cordis Corporation, patent royalties from Zimmer Spine, and financial support from Abbott Vascular and ev3 for carotid stent training. Dr Hopkins receives grant support from Boston Scientific Corporation, Cordis Corporation, and Micrus Endovascular.DisclosuresDr Hopkins has an ownership interest in APW Holding Inc, Boston Scientific Corporation, and Micrus Endovascular; receives consulting fees from Abbott Laboratories, C. R. Bard, Inc, Boston Scientific Corporation, Cordis Corporation, and Micrus Endovascular; has received honoraria from C.R. Bard, Inc, Boston Scientific Corporation, Cordis Corporation, and Medsn, Inc; and is on the board of, is a trustee of, or is an officer of Access Closure, Inc, marketRX, Inc, and Micrus Endovascular.FootnotesCorrespondence to David M. Pelz, MD, FRCPC, Neuroradiology Section, University Hospital, London Health Sciences Centre, 339 Windermere Rd, London, Ontario, Canada, N6A 5A5. E-mail [email protected], or [email protected] References 1 Topakian R, Strasak AM, Sonnberger M, Haring HP, Nussbaumer K, Trenkler J, Aichner FT. Timing of stenting of symptomatic carotid stenosis is predictive of 30-day outcome. Eur J Neurol. 2007; 14: 672–678.CrossrefMedlineGoogle Scholar2 Lam RC, Lin SC, DeRubertis B, Hynecek R, Kent KC, Faries PL. The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg. 2007; 45: 875–880.CrossrefMedlineGoogle Scholar3 Schluter M, Reimers B, Castriota F, Tubler T, Cernetti C, Cremonesi A, Berger J, Colombo A, Schofer J. Impact of diabetes, patient age, and gender on the 30-day incidence of stroke and death in patients undergoing carotid artery stenting with embolus protection: a post-hoc subanalysis of a prospective multicenter registry. J Endovasc Ther. 2007; 14: 271–278.CrossrefMedlineGoogle Scholar4 Zahn R, Ischinger T, Hochadel M, Zeymer U, Schmalz W, Treese N, Hauptmann KE, Seggewiss H, Janicke I, Haase H, Mudra H, Senges J. Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry. Eur Heart J. 2007; 28: 370–375.CrossrefMedlineGoogle Scholar5 Mehta RH, Zahn R, Hochadel M, Ischinger T, Jung J, Hauptmann KE, Mark B, Zeymer U, Schramm A, Senges J. Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry). Am J Cardiol. 2007; 99: 1288–1293.CrossrefMedlineGoogle Scholar6 Long GW, Nuthakki V, Bove PG, Brown OW, Shanley CJ, Bendick PJ, Rimar S, Kitzmiller J, Zelenock GB. Contemporary outcomes for carotid endarterectomy at a large community-based academic health center. Ann Vasc Surg. 2007; 21: 321–327.CrossrefMedlineGoogle Scholar7 Witt K, Borsch K, Daniels C, Walluscheck K, Alfke K, Jansen O, Czech N, Deuschl G, Stingele R Neuropsychological consequences of endarterectomy and endovascular angioplasty with stent placement for treatment of symptomatic carotid stenosis: A prospective randomised study. J Neurol. 2007;Epub.Google Scholar8 Maleux G, Demaerel P, Verbeken E, Daenens K, Heye S, Van Sonhoven F, Nevelsteen A, Wilms G. Cerebral ischemia after filter-protected carotid artery stenting is common and cannot be predicted by the presence of substantial amount of debris captured by the filter device. AJNR Am J Neuroradiol. 2006; 27: 830–833.MedlineGoogle Scholar9 Tedesco MM, Lee JT, Dalman RL, Lane B, Loh C, Haukoos JS, Rapp JH, Coogan SM. Postprocedural microembolic events following carotid surgery and carotid angioplasty and stenting. J Vasc Surg. 2007; 46: 244–250.CrossrefMedlineGoogle Scholar10 Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv. 2007; 69: 690–696.CrossrefMedlineGoogle Scholar11 Katzen BT, Criado FJ, Ramee SR, Massop DW, Hopkins LN, Donohoe D, Cohen SA, Mauri L. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv. 2007; 70: 316–323.CrossrefMedlineGoogle Scholar12 Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M, Hopkins LN, Atkinson R, Raabe R, Barnwell S, Green R. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv. 2007; 69: 341–348.CrossrefMedlineGoogle Scholar13 Hopkins LN for the BEACH and CABERNET Investigators. Three-year follow-up after carotid stenting in high surgical risk patients: the BEACH and CABERNET trials. Proc. of the 19th Annual Transcatheter Cardiovascular Therapeutics Conf., Washington, DC. Oct. 2007.Google Scholar14 Maynar M, Baldi S, Rostagno R, Zander T, Rabellino M, Llorens R, Alvarez J, Barajas F. Carotid stenting without use of balloon angioplasty and distal protection devices: preliminary experience in 100 cases. AJNR Am J Neuroradiol. 2007; 28: 1378–1383.CrossrefMedlineGoogle Scholar15 Centers for Medicare and Medicaid Services: Decision memo for percutaneous transluminal angioplasty (PTA) of the carotid artery concurrent with stenting (CAG-00085R3). April 30, 2007. Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=194. Accessed May 4, 2007.Google Scholar16 Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007; 38: 1531–1537.LinkGoogle Scholar17 Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery. 2007; 61: 644–651.CrossrefMedlineGoogle Scholar18 Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007; 68: 420–426.CrossrefMedlineGoogle Scholar19 Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery. 2007; 61: 236–243.CrossrefMedlineGoogle Scholar20 Interventional Management of Stroke Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007; 38: 2127–2135.LinkGoogle Scholar21 National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med. 1995; 333: 1581–1587.CrossrefMedlineGoogle Scholar22 Kim D, Jahan R, Starkman S, Abolian A, Kidwell CS, Vinuela F, Duckwiler GR, Ovbiagele B, Vespa PM, Selco S, Rajajee V, Saver JL. Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. AJNR Am J Neuroradiol. 2006; 27: 2048–2052.MedlineGoogle Scholar23 Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS, MERCI and Multi MERCI Writing Committee. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke. 2007; 38: 1274–1280.LinkGoogle Scholar24 Lum C, Stys PK, Hogan MJ, Nguyen TB, Srinivasan A, Goyal M. Acute anterior circulation stroke: recanalization using clot angioplasty. Can J Neurol Sci. 2006; 33: 217–222.CrossrefMedlineGoogle Scholar25 Sauvageau E, Samuelson, Levy EI, Jeziorski AM, Mehta RA, Hopkins LN. Middle cerebral artery stenting for acute ischemic stroke after unsuccessful MERCI retrieval. Neurosurgery. 2007; 60: 701–706.CrossrefMedlineGoogle Scholar26 Levy EI, Mehta R, Gupta R, Hanel RA, Chamczuk AJ, Fiorella D, Woo HH, Albuquerque FC, Jovin TG, Horowitz MB, Hopkins LN. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol. 2007; 28: 815–822.Google Scholar27 Lavallee PC, Mazighi M, Saint-Maurice JP, Mesequer E, Abboud H, Klein IF, Houdart E, Amarenco P. Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion. Stroke. 2007; 38: 2270–2274.LinkGoogle Scholar28 Suh DC, Kim JK, Choi CG, Kim SJ, Pyun HW, Ahn C, Yang DH, Lim KS, Leem JG, Hahm KD, Lee JH, Kwon SU, Kim JS. Prognostic factors for neurologic outcome after endovascular revascularization of acute symptomatic occlusion of the internal carotid artery. AJNR Am J Neuroradiol. 2007; 28: 1167–1171.CrossrefMedlineGoogle Scholar29 Wang H, Wang D, Fraser K, Swischuk J, Elwood P. Emergent combined intracranial thrombolysis and carotid stenting in the hyperacute management of stroke patients with severe cervical carotid stenosis. AJNR Am J Neuroradiol. 2007; 28: 1162–1166.CrossrefMedlineGoogle Scholar30 Vora NA, Gupta R, Thomas AJ, Horowitz MB, Tayal AH, Hammer MD, Uchino K, Wechsler LR, Jovin TG. Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke. AJNR Am J Neurorad. 2007; 28: 1391–1394.CrossrefMedlineGoogle Scholar31 Ikushima I, Ohta H, Hirai T, Yokogami K, Miyahara D, Maeda N, Yamashita Y. Balloon catheter disruption of middle cerebral artery thrombus in conjunction with thrombolysis for the treatment of acute middle cerebral artery embolism. AJNR Am J Neuroradiol. 2007; 28: 513–517.MedlineGoogle Scholar32 Kerber CW, Wanke I, Bernard J, Woo HH, Liu MW, Nelson PK. Rapid intracranial clot removal with a new device: the alligator retriever. AJNR Am J Neuroradiol. 2007; 28: 860–863.MedlineGoogle Scholar33 Linfante I, Wakhloo AJ. Brain aneurysms and arteriovenous malformations: advancements and emerging treatments in endovascular embolization. Stroke. 2007; 38: 1411–1417.LinkGoogle Scholar34 Kallmes DF, Cloft HJ. Ready or not, here they come: randomized trials evaluating new endovascular aneurysm therapies. AJNR Am J Neuroradiol. 2007; 28: 799–803.MedlineGoogle Scholar35 Layton KF, Cloft HJ, Gray LA, Lewis DA, Kallmes DF. Balloon-assisted coiling of intracranial aneurysms: Evaluation of local thrombus formation and symptomatic thromboembolic complications. AJNR Am J Neuroradiol. 2007; 28: 1172–1175.CrossrefMedlineGoogle Scholar36 Deguchi J, Spelle L, Piotin M, Mounayer C, Moret J. Safety and Efficacy of the Balloon-Remodelling Technique in the Endovascular Treatment of 368 Intracranial Berry Aneurysms. WFITN Proc. pp 81.Google Scholar37 Yavuz K, Geyik S, Pamuk AG, Koc O, Saatci I, Cekirge S. Immediate and midterm follow-up results of using an electrodetachable, fully retrievable SOLO stent system in the endovascular coil occlusion of wide-necked cerebral aneurysms. J Neurosurg. 2007; 107: 49–45.CrossrefGoogle Scholar38 Li MH, Li YD, Gao BL, Fang C, Luo QY, Cheng YS, Xie ZY, Wang YL, Zhao JG, Li Y, Wang W, Zhang BL, Li M. A new covered stent designed for intracranial vasculature: application in the management of pseudoaneurysms of the cranial internal carotid artery. AJNR Am J Neuroradiol. 2007; 28: 1579–1585.CrossrefMedlineGoogle Scholar39 Kallmes DF, Ding YH, Dai D, Kadirvel R, Lewis DA, Cloft HJ. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke. 2007; 38: 2346–2352.LinkGoogle Scholar40 Szikora I, Nelson PK, Berez A, Berentei Z, Kulcsar Z, Marosfoi M, Lee W, Nyary I. Treatment of Intracranial Saccular Aneurysms Using High Mesh Density Vascular Endoprosthesis: The Pipeline Vascular Reconstruction System (a). Proc. of the 9th Congress of the World Federation of Interventional and Therapeutic Neuroradiology (WFITN), Beijing, Sept. 2007, pp 114.Google Scholar41 Lee D, Yuki I, Murayama Y, Chiang A, Nishimura I, Vinters HV, Wang CJ, Nien YL, Ishii A, Wu BM, Vinuela F. Thrombus organization and healing in the swine experimental aneurysm model, Part 1: A histological and molecular analysis. J Neurosurg. 2007; 107: 94–108.CrossrefMedlineGoogle Scholar42 Yuki I, Lee D, Murayama Y, Chiang A, Vinters HV, Nishimura I, Wang CJ, Ishii A, Wu BM, Vinuela F. Thrombus organization and healing in an experimental aneurysm model, Part II: The effect of various types of bioactive bioabsorbable polymeric coils. J Neurosurg. 2007; 107: 109–119.CrossrefMedlineGoogle Scholar43 Abruzzo T, Tun T, Sambanis A. Efficient transmicrocatheter delivery of functional fibroblasts with a bioengineered collagen gel-platinum microcoil complex: toward the development of endovascular cell therapy for cerebral aneurysms. AJNR Am J Neuroradiol. 2007; 28: 1586–1593.CrossrefMedlineGoogle Scholar44 Molyneux AJ, Kerr R, Ramzi N, Birks J. International Subarachnoid Aneurysm Trial (ISAT). Proc. of the WFITN. Beijing, Sept 2007, pp 61–2.Google Scholar45 Campi A, Ramzi N, Molyneux AJ, Summers PE, Kerr RSC, Sneade M, Yarnold JA, Rischmiller J, Byrne JV. Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the International Subarachnoid Aneurysm Trial (ISAT). Stroke. 2007; 38: 1538–1544.LinkGoogle Scholar46 Wallace RC, Karis JP, Partovi S, Fiorella D. Noninvasive imaging of treated cerebral aneurysms, Part 1: MR angiographic follow-up of coiled aneurysms. AJNR Am J Neuroradiol. 2007; 28: 1001–1008.CrossrefMedlineGoogle Scholar47 Wong JH, Mitha AP, Willson M, Hudon ME, Sevick RJ, Frayne R. Assessment of brain aneurysms by using high-resolution magnetic resonance angiography after endovascular coil delivery. J Neurosurg. 2007; 107: 283–289.CrossrefMedlineGoogle Scholar48 Papke K, Kuhl CK, Fruth M, Haupt C, Schlunz-Hendann M, Sauner D, Fiebich M, Bani A, Brassel F. Intracranial aneurysms: role of multidetector CT angiography in diagnosis and endovascular therapy planning. Radiology. 2007; 244: 532–540.CrossrefMedlineGoogle Scholar49 Chang HS. Simulation of the natural history of cerebral aneurysms based on data from the International Study of Unruptured Intracranial Aneurysms. J Neurosurg. 2006; 104: 188–194.CrossrefMedlineGoogle Scholar50 Raymond J, Molyneux AJ, Fox AJ, Claiborne JS, Rouleau I, Collet J-P. TEAM: Trial on Endovascular Aneurysm Management. Proc. of WFITN, Beijing Sept 2007, pp 400.Google Scholar51 Raymond J, Meder JF, Molyneux AJ, Fox AJ, Johston SC, Collet JP, Rouleu I. Trial on endovascular treatment of unruptured aneurysms (TEAM): study monitoring and rationale for trial interruption or continuation. J Neuroradiol. 2007; 34: 33–41.CrossrefMedlineGoogle Scholar52 Winn HR, Britz GW. Unruptured aneurysms. J Neurosurg. 2006; 104: 179–182.CrossrefMedlineGoogle Scholar53 Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF. Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. AJNR Am J Neuroradiol. 2007; 28: 146–151.MedlineGoogle Scholar54 Feng L. Mannitol as an Adjunct Liquid Embolic Agent for Brain AVMs (a). Proc WFITN, pp 115.Google Scholar55 Arakawa H, Murayama Y, Davis CR, Howard DL, Baumgartner WL, Marks MP, Do HM. Endovascular embolization of the swine rete mirabile with eudragit-E 100 polymer. AJNR Am J Neuroradiol. 2007; 28: 1191–1196.CrossrefMedlineGoogle Scholar56 Hartmann A, Mast H, Choi JH, Stapf C, Mohr JP. Treatment of arteriovenous malformations of the brain. Curr Neurol Neurosurg Reports. 2007; 7: 8–34.CrossrefMedlineGoogle Scholar57 Zwienenberg-Lee M, Hartman J, Rudisill N, Muizelaar JP. Endovascular management of cerebral vasospasm. Neurosurgery. 2006; 59: S3-139–147.CrossrefGoogle Scholar58 Calderon-Arnulphi M, Alaraj A, Amin-Hanjani S, Mantulin WW, Polzonetti CM, Gratton E, Charbel FT. Detection of cerebral ischemia in neurovascular surgery using quantitative frequency-domain near-infrared spectroscopy. J Neurosurg. 2007; 106: 283–290.CrossrefMedlineGoogle Scholar59 Feldman E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, Smith HH, Nichols F, Rogg J, Cloft HJ, Wechsler L, Saver J, Levine SR, Tegeler C, Adams R, Sloan M. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology. 2007; 8: 2099–2106.Google Scholar60 Tsivgoulis G, Sharma VK, Lao AY, Malkoff MD, Alexandrov AV. Validation of transcranial doppler with computed tomography angiography in acute cerebral ischemia. Stroke. 2007; 38: 1245–1249.LinkGoogle Scholar61 Wunderlich MT, Goertler M, Postert T, Schmitt E, Seidel G, Gahn G, Samii C, Stolz E. Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology. 2007; 68: 1364–1368.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Zhu Y, Li M, Lin F, Song D, Tan H, Gu B, Zhang H, Leng B and Zhang P (2012) Frequency and predictors of endoleaks and long-term patency after covered stent placement for the treatment of intracranial aneurysms: a prospective, non-randomised multicentre experience, European Radiology, 10.1007/s00330-012-2581-4, 23:1, (287-297), Online publication date: 1-Jan-2013. Cirillo L, Dall'Olio M, Princiotta C, Simonetti L, Stafa A and Leonardi F (2010) The Use of Flow-Diverting Stents in the Treatment of Giant Cerebral Aneurysms: Preliminary Results, The Neuroradiology Journal, 10.1177/197140091002300212, 23:2, (220-224), Online publication date: 1-Apr-2010. Dion J and Maidan L (2010) Neuroendovascular Interventions Peripheral Endovascular Interventions, 10.1007/978-1-4419-1387-6_25, (369-387), . Murias E, Vega P, Gil A, Benavente L and Calleja S (2009) Tratamiento intravascular de la oclusión aguda carotídea con lesión en tándem intracraneal, Radiología, 10.1016/j.rx.2009.01.014, 51:4, (428-431), Online publication date: 1-Jul-2009. Sadasivan C, Cesar L, Seong J, Rakian A, Hao Q, Tio F, Wakhloo A and Lieber B (2009) An Original Flow Diversion Device for the Treatment of Intracranial Aneurysms, Stroke, 40:3, (952-958), Online publication date: 1-Mar-2009. Gortler D, Schlösser F, Muhs B, Nelson M and Dardik† A (2008) Periprocedural Drug Therapy in Carotid Artery Stenting: The Need for More Evidence, Vascular, 10.2310/6670.2008.00081, 16:6, (303-309), Online publication date: 1-Dec-2008. Nakatsukasa M, Inamasu J, Kuramae T and Saito K (2008) Intra-arterial thrombolysis for tandem cervical internal carotid artery/middle cerebral artery occlusion approached from the contralateral side, Nihon Kyukyu Igakukai Zasshi, 10.3893/jjaam.19.1052, 19:11, (1052-1056), . February 2008Vol 39, Issue 2 Advertisement Article InformationMetrics https://doi.org/10.1161/STROKEAHA.107.510628PMID: 18187680 Manuscript receivedNovember 23, 2007Manuscript acceptedNovember 28, 2007Originally publishedJanuary 10, 2008 Keywordsinterventional neuroradiologyadvancesPDF download Advertisement
Referência(s)